The objectives of this study were to determine the difference in the amount of visceral fat tissue between patients with and without CRA; assess the difference in serum APN levels and the presence of MetS between patients with and without CRA; and evaluate the association between the size, number, location, and histopathological characteristics of CRA and MetS and the amount of visceral fat tissue. This evidence concerns the gene ANPEP and metabolic syndrome.